Transplantation of hematopoietic stem cells in multiple sclerosis;Trasplante de progenitores hematopoyéticos en la esclerosis múltiple

Revista de Neurologia

Volumn 35, Issue 12, 2002, Pages 1136-1141

  Saiz, A ^a   Graus, Francesc ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Immunosupression; Multiple sclerosis; Transplantation

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; THYMOCYTE ANTIBODY;

ADULT; AUTOIMMUNE DISEASE; AUTOTRANSPLANTATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMIPARESIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROBABILITY; REVIEW; SCORING SYSTEM; TREATMENT OUTCOME; VEIN OCCLUSION;

EID: 0037122398     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3512.2002387     Document Type: Review

References (31)

1. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997; 19: 643-5.
2. Bansil S, Cook SD, Rohowsky-Kochan C. Multiple sclerosis: immune mechanism and update on current therapies. Ann Neurol 1995; 37 (Suppl 1): S87-101.
3. Marmont AM, van Bekkum DW. Stem cell transplantation for severe autoimmune diseases: new proposals but still unanswered questions. Bone Marrow Transplant 1995; 16: 497-8.
4. Matthews WB, Compston A, Allen TV, Martyn CN. McAlpine's multiple sclerosis. Edinburgh: Churchill-Livingstone; 1991.
5. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-11.
6. Confavreux C, Vusik S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 16: 1430-8.
7. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343: 938-52.
8. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994; 78: 399-408.
9. IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993; 43: 655-60.
10. Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol 1996; 39: 285-94.
11. Van Bekkum DW. BMT in experimental autoimmune diseases. Bone Marrow Transplant 1993; 11: 183-7.
12. Karusis DM, Slavin S, Ben-Nun A. Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation. J Neuroimmunol 1992; 39: 201-10.
13. van Gelder M, Kinwel-Bohre EMP, van Bekkum DW. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngenic BMT. Bone Marrow Transplant 1993; 11: 233-41.
14. van Gelder M, van Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant 1995; 16: 343.
15. van Gelder M, van Bekkum DW. Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplant 1996; 18: 1029-34.
16. Euler HH, Marmont AM, Bacigalupo A, Fastenrath S, Dreger P, Hoffknecht M, et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996; 88: 3621-5.
17. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 1993; 20: 137.
18. + stem cells. Blood 1994; 84 (Suppl 1): 206A.
19. Fastenrath S, Dreger P, Schmitz N. Autologous unpurged bone marrow transplantation in a patient with lymphoma and SLE: short term recurrence of antinuclear antibodies. Arthritis Rheum 1995; 38: 53Q3.
20. Marmont AM, Tyndall A, Gratwhol A, Vischer T. Hematopoietic precursor stem cell transplantation for autoimmune diseases. Lancet 1995; 345: 978.
21. Brodsky RA, Sensenbrenner LL, Jones RJ. Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Blood 1996; 87: 491.
22. Burt RK, Traynor AE, Pope R, Schroeder J, Cohen B, Karlin KH, et al. Treatment o autoimmune disease by intense immunosuppresive conditioning and autologous hematopoietic stem cell transplantation. Blood 1998; 92: 3505-14.
23. Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematological cancers. N Engl J Med 2001; 344: 175-81.
24. Openshaw H, Stuve O, Antel JP, Nash R, Lund BT, Weiner LP, et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 2000; 54: 2147-50.
25. Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant 1997; 20: 631-8.
26. Comi G, Kappos L, Clanet M, Ebers G, Fassas A, Fazekas F, et al. Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group. J Neurol 2000; 247: 376-82.
27. Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, et al. Autologous stem cell transplantation in progressive multiple sclerosis: an interin analysis of efficacy. J Clin Immunol 2000; 20: 24-30.
28. Kozák T, Havrdová E, Pitha J, Gregora E, Pytlik R, Maaloufova J, et al. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant 2000; 25: 525-31.
29. Burt RK, Traynor AE, Cohen B, Karlin KH, Davis FA, Stefoski D, et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant 1998; 21: 537-41.
30. Openshaw H, Lund BT, Kashyap A, Atkinson R, Sniecinski I, Weiner LP, et al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring. Biol Blood Marrow Transplant 2000; 6: 563-75.
31. Armitage JO. Bone marrow transplantation. N Engl J Med 1994; 330: 827-38.